Search results
Filter by type
Line of business
Category
Filter by date
210 of 290 results
This form is used by Medicare Part A providers who change the default or other contact who receives their interim rate, tentative settlement, NPR and NOC-PR determinations.
This checklist is being provided as a tool to assist providers when responding to medical record documentation requests for chemotherapy, drugs, biologicals, and injection services.
Information pertaining to end-stage renal disease, including links to LCDs/NCDs, education, FAQs, provider enrollment, CMS IOMs, and other resources.
This checklist is intended to provide health care providers with a reference for use when responding to medical documentation requests pertaining to clinical laboratory services. Health care providers retain responsibility to submit complet…
Pass-through status is determined for newly FDA-approved drug and device products on an individual basis. Review this article for more details on pass-through devices in an ambulatory surgical center (ASC).
Use this decision flowchart to assist in correctly applying the 58 modifier.
Use this decision flowchart to assist in correctly applying the 78 modifier.
Payment for ambulatory surgical centers (ASCs) are made under a separate payment system. As such, certain modifiers are specific to ASCs. This article explores these modifiers.
Medicare approved the groundbreaking new cell-based gene therapy drug, Encelto, for use in the ambulatory surgical center setting, effective for claims with dates of service on or after October 1, 2025. This article details how to bill for…
Some clinical laboratories in our jurisdiction are charging patients prior to performing services, a potential assignment violation. This article outlines Medicare regulations and potential penalties applicable to laboratories.